Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 390 entries
Sorted by: Best Match Show Resources per page
Three Cases of Intestinal Anastomosis.

British medical journal

Cripps H.
PMID: 20756886
Br Med J. 1897 Mar 27;1(1891):777-8. doi: 10.1136/bmj.1.1891.777.

No abstract available.

Cite
Cripps H. Three Cases of Intestinal Anastomosis. Br Med J. 1897;1(1891):777-8doi: 10.1136/bmj.1.1891.777.
Cripps, H. (1897). Three Cases of Intestinal Anastomosis. British medical journal, 1(1891), 777-8. https://doi.org/10.1136/bmj.1.1891.777
Cripps, H. "Three Cases of Intestinal Anastomosis." British medical journal vol. 1,1891 (1897): 777-8. doi: https://doi.org/10.1136/bmj.1.1891.777
Cripps H. Three Cases of Intestinal Anastomosis. Br Med J. 1897 Mar 27;1(1891):777-8. doi: 10.1136/bmj.1.1891.777. PMID: 20756886; PMCID: PMC2432937.
Copy Download .nbib Format: NLM
Cannabidiol, among Other Cannabinoid Drugs, Modulates Prepulse Inhibition of Startle in the SHR Animal Model: Implications for Schizophrenia Pharmacotherapy.

Frontiers in pharmacology

Peres FF, Levin R, Almeida V, Zuardi AW, Hallak JE, Crippa JA, Abilio VC.
PMID: 27667973
Front Pharmacol. 2016 Sep 09;7:303. doi: 10.3389/fphar.2016.00303. eCollection 2016.

Schizophrenia is a severe psychiatric disorder that involves positive, negative and cognitive symptoms. Prepulse inhibition of startle reflex (PPI) is a paradigm that assesses the sensorimotor gating functioning and is impaired in schizophrenia patients as well as in animal...

Cite
Peres FF, Levin R, Almeida V, et al. Cannabidiol, among Other Cannabinoid Drugs, Modulates Prepulse Inhibition of Startle in the SHR Animal Model: Implications for Schizophrenia Pharmacotherapy. Front Pharmacol. 2016;7:303doi: 10.3389/fphar.2016.00303.
Peres, F. F., Levin, R., Almeida, V., Zuardi, A. W., Hallak, J. E., Crippa, J. A., & Abilio, V. C. (2016). Cannabidiol, among Other Cannabinoid Drugs, Modulates Prepulse Inhibition of Startle in the SHR Animal Model: Implications for Schizophrenia Pharmacotherapy. Frontiers in pharmacology, 7303. https://doi.org/10.3389/fphar.2016.00303
Peres, Fernanda F, et al. "Cannabidiol, among Other Cannabinoid Drugs, Modulates Prepulse Inhibition of Startle in the SHR Animal Model: Implications for Schizophrenia Pharmacotherapy." Frontiers in pharmacology vol. 7 (2016): 303. doi: https://doi.org/10.3389/fphar.2016.00303
Peres FF, Levin R, Almeida V, Zuardi AW, Hallak JE, Crippa JA, Abilio VC. Cannabidiol, among Other Cannabinoid Drugs, Modulates Prepulse Inhibition of Startle in the SHR Animal Model: Implications for Schizophrenia Pharmacotherapy. Front Pharmacol. 2016 Sep 09;7:303. doi: 10.3389/fphar.2016.00303. eCollection 2016. PMID: 27667973; PMCID: PMC5016523.
Copy Download .nbib Format: NLM
Cellular and Molecular Targets of Benzo[a]pyrene and Metal Toxicity in Xenopus laevis Embryos and in Hep G2 Cells.

Alternatives to laboratory animals : ATLA

Camatini M, Bonfanti P, Colombo A, Urani C, Crippa S.
PMID: 25470671
Altern Lab Anim. 1999 May-Jun;27(3):325-37. doi: 10.1177/026119299902700321.

This paper describes the use of two in vitro systems (stage 35 Xenopus laevis embryos and the human hepatoblastoma cell line, Hep G2) to study effects of some environmental contaminants (benzo[a]pyrene, copper and zinc), which are representative of chemicals...

Cite
Camatini M, Bonfanti P, Colombo A, et al. Cellular and Molecular Targets of Benzo[a]pyrene and Metal Toxicity in Xenopus laevis Embryos and in Hep G2 Cells. Altern Lab Anim. 1999;27(3):325-37doi: 10.1177/026119299902700321.
Camatini, M., Bonfanti, P., Colombo, A., Urani, C., & Crippa, S. (1999). Cellular and Molecular Targets of Benzo[a]pyrene and Metal Toxicity in Xenopus laevis Embryos and in Hep G2 Cells. Alternatives to laboratory animals : ATLA, 27(3), 325-37. https://doi.org/10.1177/026119299902700321
Camatini, M, et al. "Cellular and Molecular Targets of Benzo[a]pyrene and Metal Toxicity in Xenopus laevis Embryos and in Hep G2 Cells." Alternatives to laboratory animals : ATLA vol. 27,3 (1999): 325-37. doi: https://doi.org/10.1177/026119299902700321
Camatini M, Bonfanti P, Colombo A, Urani C, Crippa S. Cellular and Molecular Targets of Benzo[a]pyrene and Metal Toxicity in Xenopus laevis Embryos and in Hep G2 Cells. Altern Lab Anim. 1999 May-Jun;27(3):325-37. doi: 10.1177/026119299902700321. PMID: 25470671.
Copy Download .nbib Format: NLM
Quenching of the excited states of 8-methoxypsoralen by synthetic Eumelanin.

Journal of fluorescence

Losi A, Viappiani C, Crippa PR.
PMID: 24234832
J Fluoresc. 1993 Sep;3(3):191-4. doi: 10.1007/BF00862741.

The interaction of 8-methoxypsoralen (8-MOP) with synthetic eumelanin was investigated using static and time-resolved fluoresence and pulsed photoacoustic calorimetry. Spectroscopic data indicate the absence of interaction in the ground state, whereas the singlet excited state of 8-MOP is quenched...

Cite
Losi A, Viappiani C, Crippa PR. Quenching of the excited states of 8-methoxypsoralen by synthetic Eumelanin. J Fluoresc. 1993;3(3):191-4doi: 10.1007/BF00862741.
Losi, A., Viappiani, C., & Crippa, P. R. (1993). Quenching of the excited states of 8-methoxypsoralen by synthetic Eumelanin. Journal of fluorescence, 3(3), 191-4. https://doi.org/10.1007/BF00862741
Losi, A, et al. "Quenching of the excited states of 8-methoxypsoralen by synthetic Eumelanin." Journal of fluorescence vol. 3,3 (1993): 191-4. doi: https://doi.org/10.1007/BF00862741
Losi A, Viappiani C, Crippa PR. Quenching of the excited states of 8-methoxypsoralen by synthetic Eumelanin. J Fluoresc. 1993 Sep;3(3):191-4. doi: 10.1007/BF00862741. PMID: 24234832.
Copy Download .nbib Format: NLM
Dental Abnormalities in Pituitary Dwarfism: A Case Report and Review of the Literature.

Case reports in dentistry

Ferrante F, Blasi S, Crippa R, Angiero F.
PMID: 28458931
Case Rep Dent. 2017;2017:5849173. doi: 10.1155/2017/5849173. Epub 2017 Mar 28.

Hypopituitarism is a disorder caused by a reduced level of trophic hormones that may be consequent on different destructive processes. The clinical manifestations depend on the type of hormone involved. A deficiency of growth hormone (GH) in children causes...

Cite
Ferrante F, Blasi S, Crippa R, et al. Dental Abnormalities in Pituitary Dwarfism: A Case Report and Review of the Literature. Case Rep Dent. 2017;2017:5849173doi: 10.1155/2017/5849173.
Ferrante, F., Blasi, S., Crippa, R., & Angiero, F. (2017). Dental Abnormalities in Pituitary Dwarfism: A Case Report and Review of the Literature. Case reports in dentistry, 20175849173. https://doi.org/10.1155/2017/5849173
Ferrante, Franco, et al. "Dental Abnormalities in Pituitary Dwarfism: A Case Report and Review of the Literature." Case reports in dentistry vol. 2017 (2017): 5849173. doi: https://doi.org/10.1155/2017/5849173
Ferrante F, Blasi S, Crippa R, Angiero F. Dental Abnormalities in Pituitary Dwarfism: A Case Report and Review of the Literature. Case Rep Dent. 2017;2017:5849173. doi: 10.1155/2017/5849173. Epub 2017 Mar 28. PMID: 28458931; PMCID: PMC5387821.
Copy Download .nbib Format: NLM
Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years.

Therapeutic advances in psychopharmacology

Dos Santos RG, Osório FL, Crippa JA, Riba J, Zuardi AW, Hallak JE.
PMID: 27354908
Ther Adv Psychopharmacol. 2016 Jun;6(3):193-213. doi: 10.1177/2045125316638008. Epub 2016 Mar 18.

To date, pharmacological treatments for mood and anxiety disorders and for drug dependence show limited efficacy, leaving a large number of patients suffering severe and persistent symptoms. Preliminary studies in animals and humans suggest that ayahuasca, psilocybin and lysergic...

Cite
Dos Santos RG, Osório FL, Crippa JA, et al. Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years. Ther Adv Psychopharmacol. 2016;6(3):193-213doi: 10.1177/2045125316638008.
Dos Santos, R. G., Osório, F. L., Crippa, J. A., Riba, J., Zuardi, A. W., & Hallak, J. E. (2016). Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years. Therapeutic advances in psychopharmacology, 6(3), 193-213. https://doi.org/10.1177/2045125316638008
Dos Santos, Rafael G, et al. "Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years." Therapeutic advances in psychopharmacology vol. 6,3 (2016): 193-213. doi: https://doi.org/10.1177/2045125316638008
Dos Santos RG, Osório FL, Crippa JA, Riba J, Zuardi AW, Hallak JE. Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years. Ther Adv Psychopharmacol. 2016 Jun;6(3):193-213. doi: 10.1177/2045125316638008. Epub 2016 Mar 18. PMID: 27354908; PMCID: PMC4910400.
Copy Download .nbib Format: NLM
A novel hybrid organic/inorganic photonic crystal slab showing a resonance action at the band edge.

Nanotechnology

Petti L, Rippa M, Zhou J, Manna L, Mormile P.
PMID: 21646692
Nanotechnology. 2011 Jul 15;22(28):285307. doi: 10.1088/0957-4484/22/28/285307. Epub 2011 Jun 07.

Here we propose and experimentally demonstrate a hybrid photonic crystal (PC) slab consisting of air rods in a nanocomposite prepared by incorporating CdSe/CdS core/shell NRs (NR) in a polymer. Since the styrene methyl acrylate based polymer (ZEP) is transparent...

Cite
Petti L, Rippa M, Zhou J, et al. A novel hybrid organic/inorganic photonic crystal slab showing a resonance action at the band edge. Nanotechnology. 2011;22(28):285307doi: 10.1088/0957-4484/22/28/285307.
Petti, L., Rippa, M., Zhou, J., Manna, L., & Mormile, P. (2011). A novel hybrid organic/inorganic photonic crystal slab showing a resonance action at the band edge. Nanotechnology, 22(28), 285307. https://doi.org/10.1088/0957-4484/22/28/285307
Petti, L, et al. "A novel hybrid organic/inorganic photonic crystal slab showing a resonance action at the band edge." Nanotechnology vol. 22,28 (2011): 285307. doi: https://doi.org/10.1088/0957-4484/22/28/285307
Petti L, Rippa M, Zhou J, Manna L, Mormile P. A novel hybrid organic/inorganic photonic crystal slab showing a resonance action at the band edge. Nanotechnology. 2011 Jul 15;22(28):285307. doi: 10.1088/0957-4484/22/28/285307. Epub 2011 Jun 07. PMID: 21646692.
Copy Download .nbib Format: NLM
Eastern Canadian Colorectal Cancer Consensus Conference: setting the limits of resectable disease.

Current oncology (Toronto, Ont.)

Vickers M, Samson B, Colwell B, Cripps C, Jalink D, El-Sayed S, Chen E, Porter G, Goel R, Villeneuve J, Sundaresan S, Asselah J, Biagi J, Jonker D, Dawson L, Letourneau R, Rother M, Maroun J, Thirlwell M, Hussein M, Tehfe M, Perrin N, Michaud N, Hammad N, Champion P, Rajan R, Burkes R, Barrette S, Welch S, Yarom N, Asmis T.
PMID: 20651901
Curr Oncol. 2010 Jun;17(3):70-7. doi: 10.3747/co.v17i3.610.

The annual Eastern Canadian Colorectal Cancer Consensus Conference was held in Montreal, Quebec, October 22-24, 2009. Health care professionals involved in the care of patients with colorectal cancer participated in presentation and discussion sessions for the purposes of developing...

Cite
Vickers M, Samson B, Colwell B, et al. Eastern Canadian Colorectal Cancer Consensus Conference: setting the limits of resectable disease. Curr Oncol. 2010;17(3):70-7doi: 10.3747/co.v17i3.610.
Vickers, M., Samson, B., Colwell, B., Cripps, C., Jalink, D., El-Sayed, S., Chen, E., Porter, G., Goel, R., Villeneuve, J., Sundaresan, S., Asselah, J., Biagi, J., Jonker, D., Dawson, L., Letourneau, R., Rother, M., Maroun, J., Thirlwell, M., Hussein, M., Tehfe, M., Perrin, N., Michaud, N., Hammad, N., Champion, P., Rajan, R., Burkes, R., Barrette, S., Welch, S., Yarom, N., & Asmis, T. (2010). Eastern Canadian Colorectal Cancer Consensus Conference: setting the limits of resectable disease. Current oncology (Toronto, Ont.), 17(3), 70-7. https://doi.org/10.3747/co.v17i3.610
Vickers, M, et al. "Eastern Canadian Colorectal Cancer Consensus Conference: setting the limits of resectable disease." Current oncology (Toronto, Ont.) vol. 17,3 (2010): 70-7. doi: https://doi.org/10.3747/co.v17i3.610
Vickers M, Samson B, Colwell B, Cripps C, Jalink D, El-Sayed S, Chen E, Porter G, Goel R, Villeneuve J, Sundaresan S, Asselah J, Biagi J, Jonker D, Dawson L, Letourneau R, Rother M, Maroun J, Thirlwell M, Hussein M, Tehfe M, Perrin N, Michaud N, Hammad N, Champion P, Rajan R, Burkes R, Barrette S, Welch S, Yarom N, Asmis T. Eastern Canadian Colorectal Cancer Consensus Conference: setting the limits of resectable disease. Curr Oncol. 2010 Jun;17(3):70-7. doi: 10.3747/co.v17i3.610. PMID: 20651901; PMCID: PMC2880907.
Copy Download .nbib Format: NLM
A false case of clozapine-resistant schizophrenia.

Case reports in medicine

Maia-de-Oliveira JP, Pinto JP, Alexandre V, Machado-de-Sousa JP, Morais SL, Chaves C, Sakamoto AC, Zuardi AW, Crippa JA, Hallak JE.
PMID: 20300582
Case Rep Med. 2010;2010:534027. doi: 10.1155/2010/534027. Epub 2010 Mar 11.

One of the subjects that most concerns physicians is treatment-resistance. About 30%-60% of schizophrenia patients do not respond adequately to antipsychotic treatment and are known as refractory schizophrenia patients. Clozapine has been the drug of choice in such cases....

Cite
Maia-de-Oliveira JP, Pinto JP, Alexandre V, et al. A false case of clozapine-resistant schizophrenia. Case Rep Med. 2010;2010:534027doi: 10.1155/2010/534027.
Maia-de-Oliveira, J. P., Pinto, J. P., Alexandre, V., Machado-de-Sousa, J. P., Morais, S. L., Chaves, C., Sakamoto, A. C., Zuardi, A. W., Crippa, J. A., & Hallak, J. E. (2010). A false case of clozapine-resistant schizophrenia. Case reports in medicine, 2010534027. https://doi.org/10.1155/2010/534027
Maia-de-Oliveira, J P, et al. "A false case of clozapine-resistant schizophrenia." Case reports in medicine vol. 2010 (2010): 534027. doi: https://doi.org/10.1155/2010/534027
Maia-de-Oliveira JP, Pinto JP, Alexandre V, Machado-de-Sousa JP, Morais SL, Chaves C, Sakamoto AC, Zuardi AW, Crippa JA, Hallak JE. A false case of clozapine-resistant schizophrenia. Case Rep Med. 2010;2010:534027. doi: 10.1155/2010/534027. Epub 2010 Mar 11. PMID: 20300582; PMCID: PMC2837900.
Copy Download .nbib Format: NLM
Optical properties of melanin; a comment.

Applied optics

Bridelli MG, Crippa PR.
PMID: 20396099
Appl Opt. 1982 Aug 01;21(15):2669-70. doi: 10.1364/AO.21.002669.

No abstract available.

Cite
Bridelli MG, Crippa PR. Optical properties of melanin; a comment. Appl Opt. 1982;21(15):2669-70doi: 10.1364/AO.21.002669.
Bridelli, M. G., & Crippa, P. R. (1982). Optical properties of melanin; a comment. Applied optics, 21(15), 2669-70. https://doi.org/10.1364/AO.21.002669
Bridelli, M G, and Crippa, P R. "Optical properties of melanin; a comment." Applied optics vol. 21,15 (1982): 2669-70. doi: https://doi.org/10.1364/AO.21.002669
Bridelli MG, Crippa PR. Optical properties of melanin; a comment. Appl Opt. 1982 Aug 01;21(15):2669-70. doi: 10.1364/AO.21.002669. PMID: 20396099.
Copy Download .nbib Format: NLM
Prolapse of the Upper into the Lower Part of the Rectum without External Protrusion.

British medical journal

Cripps H.
PMID: 20751813
Br Med J. 1887 Feb 26;1(1365):447-9. doi: 10.1136/bmj.1.1365.447.

No abstract available.

Cite
Cripps H. Prolapse of the Upper into the Lower Part of the Rectum without External Protrusion. Br Med J. 1887;1(1365):447-9doi: 10.1136/bmj.1.1365.447.
Cripps, H. (1887). Prolapse of the Upper into the Lower Part of the Rectum without External Protrusion. British medical journal, 1(1365), 447-9. https://doi.org/10.1136/bmj.1.1365.447
Cripps, H. "Prolapse of the Upper into the Lower Part of the Rectum without External Protrusion." British medical journal vol. 1,1365 (1887): 447-9. doi: https://doi.org/10.1136/bmj.1.1365.447
Cripps H. Prolapse of the Upper into the Lower Part of the Rectum without External Protrusion. Br Med J. 1887 Feb 26;1(1365):447-9. doi: 10.1136/bmj.1.1365.447. PMID: 20751813; PMCID: PMC2534190.
Copy Download .nbib Format: NLM
Canadian supportive care recommendations for the management of neutropenia in patients with cancer.

Current oncology (Toronto, Ont.)

Kouroukis CT, Chia S, Verma S, Robson D, Desbiens C, Cripps C, Mikhael J.
PMID: 18317581
Curr Oncol. 2008 Jan;15(1):9-23. doi: 10.3747/co.2008.198.

Hematologic toxicities of cancer chemotherapy are common and often limit the ability to provide treatment in a timely and dose-intensive manner. These limitations may be of utmost importance in the adjuvant and curative intent settings. Hematologic toxicities may result...

Cite
Kouroukis CT, Chia S, Verma S, et al. Canadian supportive care recommendations for the management of neutropenia in patients with cancer. Curr Oncol. 2008;15(1):9-23doi: 10.3747/co.2008.198.
Kouroukis, C. T., Chia, S., Verma, S., Robson, D., Desbiens, C., Cripps, C., & Mikhael, J. (2008). Canadian supportive care recommendations for the management of neutropenia in patients with cancer. Current oncology (Toronto, Ont.), 15(1), 9-23. https://doi.org/10.3747/co.2008.198
Kouroukis, C T, et al. "Canadian supportive care recommendations for the management of neutropenia in patients with cancer." Current oncology (Toronto, Ont.) vol. 15,1 (2008): 9-23. doi: https://doi.org/10.3747/co.2008.198
Kouroukis CT, Chia S, Verma S, Robson D, Desbiens C, Cripps C, Mikhael J. Canadian supportive care recommendations for the management of neutropenia in patients with cancer. Curr Oncol. 2008 Jan;15(1):9-23. doi: 10.3747/co.2008.198. PMID: 18317581; PMCID: PMC2259432.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 390 entries